Updating results

What are the risk factors for diverticulosis progressing to diverticular disease?

Recommendation ID NG147/6 Question What are the risk factors for diverticulosis progressing to diverticular disease? Any explanatory

Research recommendation Published February 2020

Can risk of contrast-induced acute kidney injury be stratified by eGFR thresholds?

Recommendation ID NG148/1 Question Can risk of contrast-induced acute kidney injury be stratified by eGFR thresholds? Any explanatory

Research recommendation Published February 2020

The committee recommended studies to collect data on the rates of cancelled CT scans, whether cancelled appointments are filled and the effect on patients' experience before and after the introduction of point-of-care (POC) creatinine devices to radiology departments.

Recommendation ID DG37/3 Question The committee recommended studies to collect data on the rates of cancelled CT scans, whether cancelled

Research recommendation Published February 2020

The committee recommended that a suitable risk factor screening tool for identifying risk of PC‑AKI for use across the NHS in people presenting for an outpatient CT scan with contrast agent is developed or an existing tool is validated.

Recommendation ID DG37/2 Question The committee recommended that a suitable risk factor screening tool for identifying risk of PC‑AKI for

Research recommendation Published February 2020

The committee recommended further research on the incidence and effect of post-contrast acute kidney injury (PC‑AKI) in people with eGFR less than 30 ml/min/1.73 m2.

Recommendation ID DG37/1 Question The committee recommended further research on the incidence and effect of post-contrast acute kidney

Research recommendation Published February 2020

What is the effectiveness, cost effectiveness and acceptability of social prescribing for carers?

Recommendation ID NG150/5 Question What is the effectiveness, cost effectiveness and acceptability of social prescribing for carers?

Research recommendation Published February 2020

What is the effectiveness, cost effectiveness and acceptability of carer passport schemes?

Recommendation ID NG150/4 Question What is the effectiveness, cost effectiveness and acceptability of carer passport schemes? Any

Research recommendation Published February 2020

What is the clinical and cost effectiveness of percutaneous thermal ablation for benign thyroid nodules?

Recommendation ID NG145/9 Question What is the clinical and cost effectiveness of percutaneous thermal ablation for benign thyroid nodules

Research recommendation Published February 2020

What is the clinical and cost effectiveness of antibiotics for the management of acute diverticulitis in primary care?

Recommendation ID NG147/1 Question What is the clinical and cost effectiveness of antibiotics for the management of acute diverticulitis

Research recommendation Published February 2020

What is the clinical and cost effectiveness of a block and replace regimen compared with a titration regimen of antithyroid drugs for Graves' disease?

Recommendation ID NG145/8 Question What is the clinical and cost effectiveness of a block and replace regimen compared with a titration

Research recommendation Published February 2020

What is the clinical and cost effectiveness of different durations of antithyroid drug regimens for people with T3 thyrotoxicosis due to Graves' disease?

Recommendation ID NG145/6 Question What is the clinical and cost effectiveness of different durations of antithyroid drug regimens for

Research recommendation Published February 2020

Are there subgroups of people with Graves' disease who have a particularly good response to antithyroid drugs?

Recommendation ID NG145/3 Question Are there subgroups of people with Graves' disease who have a particularly good response to antithyroid

Research recommendation Published February 2020

What is the minimum air exchange rate to minimise the health effects of poor indoor air quality in the home?

Recommendation ID NG149/3 Question What is the minimum air exchange rate to minimise the health effects of poor indoor air quality in the

Research recommendation Published February 2020

What interventions are effective and cost effective in supporting return to work, in all workplaces including micro-, small- and medium-sized organisations, after long-term sickness absence in the UK?

Recommendation ID NG146/1 Question What interventions are effective and cost effective in supporting return to work, in all workplaces

Research recommendation Published February 2020

For people with common mental health conditions, what interventions are effective and cost effective in reducing long-term sickness absence and supporting return to work in the UK?

Recommendation ID NG146/3 Question For people with common mental health conditions, what interventions are effective and cost effective

Research recommendation Published February 2020

What interventions are effective and cost effective in supporting return to work after recurrent short-term sickness absence in the UK?

Recommendation ID NG146/2 Question What interventions are effective and cost effective in supporting return to work after recurrent short-term

Research recommendation Published February 2020

For people with common mental health conditions, what interventions are effective and cost effective in reducing recurrent short-term sickness absence and supporting return to work in the UK?

Recommendation ID NG146/4 Question For people with common mental health conditions, what interventions are effective and cost effective

Research recommendation Published February 2020

What is the effectiveness and safety of sacral nerve stimulation and transanal irrigation compared to symptomatic treatment for people with major low anterior resection syndrome?

Recommendation ID NG151/2 Question What is the effectiveness and safety of sacral nerve stimulation and transanal irrigation compared to

Research recommendation Published February 2020

What is the most clinically and cost-effective treatment for diverticular disease?

Recommendation ID NG147/3 Question What is the most clinically and cost-effective treatment for diverticular disease? Any explanatory

Research recommendation Published February 2020

What is the clinical and cost effectiveness of levothyroxine for people under 65 with symptomatic subclinical hypothyroidism?

Recommendation ID NG145/7 Question What is the clinical and cost effectiveness of levothyroxine for people under 65 with symptomatic subclinical

Research recommendation Published February 2020

What is the long-term clinical and cost effectiveness, including safety, of radioactive iodine for hyperthyroidism?

Recommendation ID NG145/4 Question What is the long-term clinical and cost effectiveness, including safety, of radioactive iodine for hyperthyroidism

Research recommendation Published February 2020

Which interventions are effective and cost effective in supporting people working in organisations where employees are not centrally located to return to work after long-term sickness absence in the UK?

Recommendation ID NG146/6 Question Which interventions are effective and cost effective in supporting people working in organisations where

Research recommendation Published February 2020

What is the clinical and cost effectiveness of iodine for people with subclinical hypothyroidism?

Recommendation ID NG145/10 Question What is the clinical and cost effectiveness of iodine for people with subclinical hypothyroidism?

Research recommendation Published February 2020

What is the clinical and cost effectiveness of cannabis-based medicinal products as an add-on treatment for adults with persistent nausea or vomiting not caused by chemotherapy which hasn't fully responded to optimised conventional antiemetics?

Recommendation ID NG144/8 Question What is the clinical and cost effectiveness of cannabis-based medicinal products as an add-on treatment

Research recommendation Published February 2020

What is the clinical and cost effectiveness of cannabis-based medicinal products as an add-on treatment for babies, children and young people with persistent nausea or vomiting not caused by chemotherapy which hasn't fully responded to optimised conventional antiemetics?

Recommendation ID NG144/9 Question What is the clinical and cost effectiveness of cannabis-based medicinal products as an add-on treatment

Research recommendation Published February 2020

Evidence on the safety of irreversible electroporation for primary liver cancer shows serious but infrequent and well-recognised complications. Evidence on its efficacy is inadequate in quantity and quality. Therefore, this procedure should only be used in the context of research.

Recommendation ID IPG664/1 Question Evidence on the safety of irreversible electroporation for primary liver cancer shows serious but infrequent

Research recommendation Published February 2020

What is the clinical and cost effectiveness of treatment (antithyroid drugs or radioactive iodine) for improving long-term health outcomes for people with subclinical hyperthyroidism?

Recommendation ID NG145/2 Question What is the clinical and cost effectiveness of treatment (antithyroid drugs or radioactive iodine) for

Research recommendation Published February 2020

What is the effectiveness, cost effectiveness and acceptability of the whole family approach to carers' assessments?

Recommendation ID NG150/1 Question What is the effectiveness, cost effectiveness and acceptability of the whole family approach to carers'

Research recommendation Published February 2020

The percentage of women, on the register, prescribed an oral or patch contraceptive method in the preceding 12 months who have also received information from the contractor about long acting reversible methods of contraception in the preceding 12 months (Inherited)

The percentage of women, on the register, prescribed an oral or patch contraceptive method in the preceding 12 months who have also received...

General practice indicator suitable for use in the QOF Published February 2020

NICEimpact dementia

How NICE recommendations are being used to improve outcomes in priority areas of dementia care

Published February 2020 Last updated February 2020

Senior Management Team

Biographies of the NICE senior management team and minutes of their meetings

Published February 2020 Last updated February 2020

Public Involvement Programme

We support the involvement of people who use services, carers, members of the public and organisations who represent their interests across NICE. Our

Published February 2020 Last updated February 2020

Abortion care

Everything NICE has said on abortion care in an interactive flowchart.

NICE Pathway Published September 2019 Last updated February 2020

Quality Standards Advisory Committee 1 members

Find out more about the quality standards advisory committee 1 members

Published February 2020 Last updated February 2020

Resource planner (formerly known as the forward planner)

Our tool to help you plan for and implement NICE guidance. View upcoming guidance and understand the impact of guidance on your resources. Previously known as the forward planner.

Published February 2020 Last updated February 2020

Masterclasses for voluntary and community sector organisations

Workshops to help voluntary and community sector organisations learn more about NICE's activities

Published February 2020 Last updated February 2020

Waterstones

Provider name: Waterstones Lot details Lot 2 Agent - Print Books Provider helpdesk Customer Account Manager - Michelle

Published February 2020 Last updated February 2020

Public Health Advisory Committees

Public Health Advisory Committees (PHACs) are the standing committees responsible for the development of NICE public health guidance. Each PHAC...

Published February 2020 Last updated February 2020

Broader types of data to be used in development of NICE guidance

An expanded evidence base could allow NICE to address evidence gaps and enhance reviews of the impact of our guidance

News Published February 2020 Last updated February 2020

Appeal panel rules that NICE needs to request evidence for erenumab effectiveness in subgroup of people with chronic migraine

NICE has today (4 February 2020) published the outcome of the appeal against its final draft guidance (FAD) on erenumab (also called Aimovig and made by Novartis) for preventing chronic migraine.

News Published February 2020 Last updated February 2020